Drugs for Sinoatrial Node Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 54)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Propafenone |
Approved |
Phase 4 |
|
54063-53-5 |
4932
|
Synonyms:
1-(2-(2-hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl-1-propanone
1-(2-(2-Hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl-1-propanone
1-(2-(2-Hydroxy-3-propylaminopropoxy)phenyl)-3-phenylpropan-1-one
1-[2-(2-Hydroxy-3-(propylamino)propoxy)phenyl]-3-phenyl-1-propanone hydrochloride
1-[2-(2-Hydroxy-3-[propylamino]- propoxy)phenyl]-3-phenyl-1-propanone
1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylpropan-1-one
107300-59-4
2-(2'-Hydroxy-3'-propylaminopropoxy)-omega-phenylpropiophenone
2-(2'-hydroxy-3'-propylaminopropoxy)-ω-phenylpropiophenone
34183-22-7 (hydrochloride)
54063-53-5
AB00053687
Abbott brand OF propafenone hydrochloride
AC1L1J9C
AKOS000276940
Aliud brand OF propafenone hydrochloride
Alpharma brand OF propafenone hydrochloride
apo-Propafenone
Apotex brand OF propafenone hydrochloride
Arythmol
Azupharma brand OF propafenone hydrochloride
Baxarytmon
BCBcMAP01_000079
BPBio1_000437
BRD-A26334849-001-02-1
BRD-A26334849-003-05-0
BSPBio_000397
BSPBio_001465
BSPBio_003470
C07381
CHEBI:127112
CHEMBL631
CID4932
CPD001453705
Cuxafenon
D08435
DB01182
DivK1c_000906
EINECS 258-955-6
Fenoprain
Hexal brand OF propafenone
HMS1791J07
HMS1989J07
HMS2089E09
Hydrochloride, propafenone
IDI1_000906
Juta brand OF propafenone hydrochloride
Jutanorm
KBio1_000906
KBio2_002092
KBio2_004660
KBio2_007228
KBio3_002974
KBioGR_000817
KBioSS_002092
Kendrick brand OF propafenone hydrochloride
Knoll brand OF propafenone hydrochloride
Lopac0_000919
LS-123071
|
Merck dura brand OF propafenone hydrochloride
MolPort-000-881-283
MolPort-002-545-323
NCGC00015819-10
NCGC00089784-02
NCGC00089784-03
NCGC00089784-04
NCGC00089784-05
NINDS_000906
Nistaken
Norfenon
P4670_SIGMA
Pintoform
Prestwick0_000499
Prestwick1_000499
Prestwick2_000499
Prestwick3_000499
Prolecofen
Propafenon al
Propafenon hexal
Propafenon Hexal
Propafenon hexal (TN)
Propafenon minden
Propafenona
Propafenona [INN-Spanish]
propafenone
Propafenone (INN)
Propafenone [INN:BAN]
Propafenone HCl
Propafenone hydrochloride
Propafenone hydrochloride, (R)-isomer
Propafenone hydrochloride, (S)-isomer
Propafenone, (+-)-isomer
Propafenone, (R)-isomer
Propafenone, (S)-isomer
Propafenone-HCl
Propafenonum
Propafenonum [INN-Latin]
Propamerck
Q-Pharm brand OF propafenone hydrochloride
Rythmol
Rythmol SR
Rytmogenat
Rytmonorm
rytmo-Puren
S2500_Selleck
SA 79
SA-79
SAM002564228
SBB067234
SPBio_001605
SPBio_002318
Spectrum_001612
Spectrum2_001603
Spectrum3_001905
Spectrum4_000209
Spectrum5_001271
TAD brand OF propafenone hydrochloride
UNII-68IQX3T69U
|
|
2 |
|
Sotalol |
Approved |
Phase 4 |
|
959-24-0, 3930-20-9 |
5253
|
Synonyms:
.beta.-Cardone
27948-47-6
3930-20-9
4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide
4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulphonanilide
4'-(1-Hydroxy-2-isopropylaminoethyl)methanesulfonanilid
959-24-0 (mono-hydrochloride)
AB00514715
AC-19021
AC1L1JXU
b-Cardone
beta-Cardone
Betapace
Betapace AF
BPBio1_001069
BRD-A33168282-003-03-2
BSPBio_000971
C07309
C12H20N2O3S
CCRIS 4204
CHEMBL471
CID5253
d,l-Sotalol
D08525
Darob
Darob mite
Darob mite (TN)
DB00489
HMS2089K09
Knoll pharmaceutical brand OF sotalol
L013427
|
Lopac0_001055
LS-90249
Methanesulfonamide, N-(4-(1-hydroxy-2-((1-methylethyl)amino)ethyl)phenyl)- (9CI)
MJ-1999
MolPort-002-042-381
N-(4-{1-hydroxy-2-[(1-methylethyl)amino]ethyl}phenyl)methanesulfonamide
N-[4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl]methanesulfonamide
N-{4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl}methanesulfonamide
NCGC00015919-05
NCGC00024899-02
NCGC00024899-03
Prestwick0_000966
Prestwick1_000966
Prestwick2_000966
Prestwick3_000966
SBB066409
Sorine
sotalol
Sotalol
Sotalol (INN)
Sotalol [INN:BAN]
Sotalol HCL
Sotalol hydrochloride
Sotalol monohydrochloride
Sotalol Monohydrochloride
Sotalolo
Sotalolum
Sotalolum [INN-Latin]
SPBio_002892
UNII-A6D97U294I
β-cardone
|
|
3 |
|
Amiodarone |
Approved, Investigational |
Phase 4 |
|
1951-25-3 |
2157
|
Synonyms:
(2-{4-[(2-butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}ethyl)diethylamine
(2-butyl-1-benzofuran-3-yl)(4-{[2-(diethylamino)ethyl]oxy}-3,5-diiodophenyl)methanone
(2-butyl-1-benzofuran-3-yl)-[4-(2-diethylaminoethyloxy)-3,5-diiodophenyl]methanone
(2-butyl-1-benzofuran-3-yl){4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl}methanone
(2-Butyl-3-benzofuranyl)(4-(2-(diethylamino)ethoxy)-3,5-diidophenyl)methanone
(2-butylbenzofuran-3-yl)-[4-(2-diethylaminoethoxy)-3,5-diiodo-phenyl]-methanone
1951-25-3
2-Butyl-3-(3,5-diiodo-4-(2-diethylaminoethoxy)benzoyl)benzofuran
2-Butyl-3-(3,5-diiodo-4-(beta-diethylaminoethoxy)benzoyl)benzofuran
2-Butyl-3-(4'-beta-N-diethylaminoethoxy-3',5'-diiodobenzoyl)benzofuran
2-Butyl-3-[3,5-diiodo-4-(2-di
2-Butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl ketone
2-Butyl-3-benzofuranyl p-((2-diethylamino)ethoxy)-m,m-diiodophenyl ketone
2-Butyl-3-benzofuranyl p-[(2-diethylamino)ethoxy]-m,m-diiodophenyl ketone
2-n-Butyl-3',5'-diiodo-4'-N-diethylaminoethoxy-3-benzoylbenzofuran
2-N-Butyl-3',5'-diiodo-4'-N-diethylaminoethoxy-3-benzoylbenzofuran
5-18-02-00353 (Beilstein Handbook Reference)
AB00053422
AC1L1D1R
AC1Q2VCU
Alphapharm brand OF amiodarone hydrochloride
Alphapharm Brand of Amiodarone Hydrochloride
Amidorone
Aminodarone
Amio-Aqueous IV
Amiobeta
Amiodarex
Amiodarona
Amiodarona [INN-Spanish]
amiodarone
Amiodarone (USAN/INN)
Amiodarone [USAN:BAN:INN]
Amiodarone base
Amiodarone Base
Amiodarone HCL
Amiodarone hydrochloride
Amiodarone Hydrochloride
Amiodarons
Amiodaronum
Amiodaronum [INN-Latin]
Amiohexal
Amjodaronum
Ancar
Aratac
Armstrong brand OF amiodarone hydrochloride
Armstrong Brand of Amiodarone Hydrochloride
Arycor
ASTA medica brand OF amiodarone hydrochloride
ASTA Medica Brand of Amiodarone Hydrochloride
Berenguer infale brand OF amiodarone hydrochloride
Berenguer Infale Brand of Amiodarone Hydrochloride
Betapharm brand OF amiodarone hydrochloride
Betapharm Brand of Amiodarone Hydrochloride
BIDD:GT0425
BIDD:PXR0146
Bio1_000026
Bio1_000515
Bio1_001004
Bio2_000294
Bio2_000774
BPBio1_000372
Braxan
BRN 1271711
BSPBio_000338
BSPBio_001574
BSPBio_002580
C06823
C25H29I2NO3
CAS-19774-82-4
CBiol_001740
CHEBI:2663
CHEMBL633
CID2157
Corbionax
Cordarex
Cordarone
Cordarone Intravenous
D000638
D02910
DB01118
DivK1c_000079
EINECS 217-772-1
ethylaminoethoxy)benzoyl]benzofuran
g Gam brand OF amiodarone hydrochloride
|
G Gam Brand of Amiodarone Hydrochloride
Hexal brand OF amiodarone hydrochloride
Hexal Brand of Amiodarone Hydrochloride
HMS1791O16
HMS1989O16
HMS2089C07
Hydrochloride, amiodarone
IDI1_000079
IDI1_034044
KBio1_000079
KBio2_000294
KBio2_000741
KBio2_002862
KBio2_003309
KBio2_005430
KBio2_005877
KBio3_000587
KBio3_000588
KBio3_001800
KBioGR_000294
KBioGR_001859
KBioSS_000294
KBioSS_000741
Ketone, 2-butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl
Ketone, 2-butyl-3-benzofuranyl 4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl (7CI,8CI)
Kordaron
L 3428
L001174
L3428
L-3428
Labaz
Leurquin brand OF amiodarone hydrochloride
Leurquin Brand of Amiodarone Hydrochloride
Lopac0_000122
Lopac-A-8423
LS-87088
MolPort-003-703-670
NCGC00015096-01
NCGC00015096-02
NCGC00015096-03
NCGC00015096-10
NCGC00024242-03
NCGC00024242-04
NCGC00024242-05
NCGC00024242-06
nchembio.79-comp9
nchembio732-comp1
NCI60_041885
NINDS_000079
on
Ortacrone
Pacerone
Pharma investi brand OF amiodarone hydrochloride
Pharma Investi Brand of Amiodarone Hydrochloride
pms-Amiodarone
Prestwick0_000409
Prestwick1_000409
Prestwick2_000409
Prestwick3_000409
QTL1_000008
Rytmarone
Sanofi winthrop brand OF amiodarone hydrochloride
Sanofi Winthrop Brand of Amiodarone Hydrochloride
Sedacoron
Sedacorone
SKF 33134 a
SKF 33134-a
SKF 33134A
SKF 33134-A
SPBio_001825
SPBio_002277
Spectrum_000261
Spectrum2_001813
Spectrum3_001050
Spectrum4_001190
Spectrum5_001533
STK529812
STOCK1S-12240
Tachydaron
Trangorex
UNII-N3RQ532IUT
UNM000001215003
Wyeth brand OF amiodarone hydrochloride
Wyeth Brand of Amiodarone Hydrochloride
|
|
4 |
|
Atenolol |
Approved |
Phase 4 |
|
29122-68-7 |
2249
|
Synonyms:
( inverted question mark)-Atenolol
(?)-Atenolol
(+-)-4-(2-Hydroxy-3-isopropylaminopropoxy)phenylacetamide
(+-)-Atenolol
(+/-)-4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetamide
(1)-2-(4-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide
1-p-Carbamoylmethylphenoxy-3-isopropylamino-2-propanol
1-P-Carbamoylmethylphenoxy-3-isopropylamino-2-propanol
2-(4-(2-Hydroxy-3-isopropylaminopropoxy)phenyl)acetamid
2-(4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl)acetamide
2-(p-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide
2-(P-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide
2-[4-({2-hydroxy-3-[(1-methylethyl)amino]propyl}oxy)phenyl]acetamide
2-[4-(2-Hydroxy-3-isopropylaminopropoxy)phenyl]acetamide
2-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide
2-{4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}acetamide
29122-68-7
4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetamide
4-[2 -Hydroxy-3 -(isopropylamino)-propoxy]phenylacetamide
4-[2'-Hydroxy-3'-(isopropylamino)propoxy]phenylacetamide
60966-51-0
A 7655
A7655_SIGMA
AC-11142
AC1L1D99
AC1Q1QBX
Acetamide,2-(p-(2-hydroxy-3-(isopropylamino)propoxy)phenyl)
Aircrit
AKOS005111050
Alinor
Altol
Anselol
Antipressan
apo-Atenolol
Apo-Atenolol
ARONIS23884
Atcardil
Atecard
Atehexal
Atenblock
Atendol
Atenet
Ateni
Atenil
Atenol
Atenol 1a pharma
Atenol 1A pharma
Atenol 1A Pharma
Atenol acis
Atenol Acis
Atenol al
Atenol AL
Atenol atid
Atenol Atid
Atenol cophar
Atenol Cophar
Atenol ct
Atenol CT
Atenol fecofar
Atenol Fecofar
Atenol gador
Atenol Gador
Atenol genericon
Atenol Genericon
Atenol GNR
Atenol heumann
Atenol Heumann
Atenol MSD
Atenol NM pharma
Atenol NM Pharma
Atenol nordic
Atenol Nordic
Atenol PB
Atenol quesada
Atenol Quesada
Atenol stada
Atenol Stada
Atenol tika
Atenol Tika
Atenol trom
Atenol Trom
Atenol von ct
Atenol von CT
Atenol Von CT
Atenolin
Atenol-mepha
Atenol-Mepha
atenolol
Atenolol (JP15/USP/INN)
Atenolol [USAN:INN:BAN:JAN]
Atenololum
Atenololum [INN-Latin]
Atenol-ratiopharm
Atenol-Ratiopharm
Atenol-wolff
Atenol-Wolff
Atenomel
Atereal
Aterol
BB_SC-1519
benzeneacetamide, 4-[2'-hydroxy-3
Betablok
Betacard
Betasyn
Betatop ge
Betatop Ge
Betatop GE
BIM-0050109.0001
Blocotenol
Blokium
BRD-A20239487-001-02-5
BRN 2739235
BSPBio_002915
Cardaxen
Cardiopress
CCRIS 4196
CHEBI:2904
CHEMBL24
CID2249
|
Corotenol
CPD000036768
Cuxanorm
D001262
D00235
DB00335
DivK1c_000057
Duraatenolol
duratenol
Duratenol
EINECS 249-451-7
EINECS 262-544-7
EU-0100121
Evitocor
Farnormin
felo-Bits
Felo-Bits
Hipres
HMS1569L13
HMS1921H09
HMS2090I19
HMS2092D19
HMS500C19
HSDB 6526
Hypoten
I01-3572
Ibinolo
ICI 66,082
ICI 66082
ICI66082
ICI-66082
IDI1_000057
InChI=1/C14H22N2O3/c1-10(2)16-8-12(17)9-19-13-5-3-11(4-6-13)7-14(15)18/h3-6,10,12,16-17H,7-9H2,1-2H3,(H2,15,18)
Internolol
Jenatenol
Juvental
KBio1_000057
KBio2_001844
KBio2_004412
KBio2_006980
KBio3_002415
KBioGR_000790
KBioSS_001844
L000116
Lopac0_000121
lo-Ten
Loten
Lo-ten
Lo-Ten
Lotenal
LS-28557
LS-9707
MLS000069622
MLS001066372
MLS001074163
MLS001304038
MolPort-001-792-717
Myocord
NCGC00015007-07
NCGC00015007-13
NCGC00024566-03
NCGC00024566-04
NCGC00024566-05
NCGC00024566-06
NCGC00024566-07
Neatenol
NINDS_000057
Normalol
Normiten
Noten
Oprea1_448775
Oraday
Ormidol
Panapres
Plenacor
Premorine
Prenolol
Prenormine
Prinorm
SAM002564193
Scheinpharm atenol
Scheinpharm Atenol
Seles beta
Seles Beta
Selobloc
Serten
Servitenol
SMR000036768
SPBio_001482
Spectrum_001364
SPECTRUM1501127
Spectrum2_001411
Spectrum3_001448
Spectrum4_000435
Spectrum5_001509
Stermin
STK528649
Tenidon
Teno-basan
Teno-Basan
Tenobloc
Tenoblock
Tenolol
Tenoprin
Tenoretic
Tenormin
Tenormin (TN)
Tenormine
Tenormine [French]
Tensimin
Tensotin
Tredol
Unibloc
UNII-50VV3VW0TI
Uniloc
Vascoten
Vericordin
Wesipin
Xaten
|
|
5 |
|
Nebivolol |
Approved, Investigational |
Phase 4 |
|
99200-09-6, 152520-56-4, 118457-14-0 |
71301
|
Synonyms:
1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)-2-[[2-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)-2-hydroxyethyl]amino]ethanol
1,1'-[Bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)]-2,2'-iminodiethanol
1,1'-Bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)-2,2'-iminodiethanol
104365-59-5
118457-14-0
2,2'-iminobis[1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)ethanol]
99200-09-6
a,Alpha'-(iminobismethylene)bis-(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol)
AC-1611
AC1L2FX8
AC1Q4OMF
alpha,alpha'-(iminobis(methylene))bis(6-fluoro-3,4-dihydro)-2H-1-benzopyran-2-methanol
alpha,Alpha'-(iminobis(methylene))bis(6-fluoro-3,4-dihydro)-2H-1-benzopyran-2-methanol
alpha,alpha'-(Iminobis(methylene))bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol)
alpha,alpha'-(iminobismethylene)bis-(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol)
alpha,Alpha'-(iminobismethylene)bis-(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol)
alpha,alpha'-(iminodimethylene)bis-(6-fluoro-2-chromanmethanol)
alpha,alpha'-(Iminodimethylene)bis(6-fluoro-2-chromanmethanol)
Bystolic
C22H25F2NO4
CHEMBL434394
CID71301
D05127
DB04861
Hydrochloride, nebivolol
I06-0378
L001284
|
Lobivon
LS-178404
MolPort-003-849-343
Narbivolol
Nebicard-5
Nebilet
Nebilong
Nebipill
Nebivolol
Nebivolol (USAN/INN)
Nebivolol [USAN:INN:BAN]
Nebivolol hydrochloride
Nebivololum
nebivololum [latin]
Nebivololum [Latin]
Nodon
Nubeta
PDSP1_000244
PDSP2_000243
PI-21858
R 67555
R65,824
R-67555
Silostar
UNII-030Y90569U
α,alpha'-(iminobismethylene)bis-(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol)
|
|
6 |
|
Ethanol |
Approved |
Phase 4 |
|
64-17-5 |
702
|
Synonyms:
(C6-C9)Alkyl alcohol
[CH2Me(OH)]
[OEtH]
02483_FLUKA
02851_FLUKA
02853_FLUKA
02854_FLUKA
02855_FLUKA
02856_FLUKA
02856_SIAL
02857_FLUKA
02857_SIAL
02858_FLUKA
02858_SIAL
02860_FLUKA
02865_FLUKA
02865_SIAL
02870_FLUKA
02870_SIAL
02875_FLUKA
02877_FLUKA
02878_FLUKA
02882_FLUKA
02882_SIAL
02883_FLUKA
02884_FLUKA
02890_FLUKA
02890_SIAL
02891_FLUKA
02891_SIAL
100C.NPA
121182-78-3
187380_ALDRICH
187380_SIAL
1-Hydroxyethane
24102_RIEDEL
24102_SIAL
24103_RIEDEL
24103_SIAL
24105_RIEDEL
24105_SIAL
24106_RIEDEL
24106_SIAL
24194_RIEDEL
24194_SIAL
245119_ALDRICH
245119_SIAL
270741_ALDRICH
270741_SIAL
277649_ALDRICH
277649_SIAL
2858_SIGMA
29221_FLUKA
32205_RIEDEL
32205_SIAL
32221_RIEDEL
32221_SIAL
32294_RIEDEL
32294_SIAL
34870_SIAL
34963_RIEDEL
39278_FLUKA
40210_ALDRICH
40210_RIEDEL
41322_FLUKA
458600_ALDRICH
458600_SIAL
459828_ALDRICH
459828_SIAL
459836_ALDRICH
459836_SIAL
459844_SIAL
48075_SUPELCO
493511_SIAL
493538_ALDRICH
493538_SIAL
493546_ALDRICH
493546_SIAL
64-17-5
676829_SIAL
68475-56-9
71076-86-3
71329-38-9
8000-16-6
8024-45-1
absolute alcohol
Absolute alcohol
Absolute Alcohol
Absolute ethanol
Absolute Ethanol
Absolute ethyl alcohol
AC1L19TW
AC1Q31MM
Aethanol
Aethanol [German]
Aethylalkohol
AHD 2000
AI3-01706
Alcare hand degermer
Alcare Hand Degermer
alcohol
Alcohol
Alcohol (ethyl)
Alcohol (USP)
Alcohol [USP]
ALCOHOL 5% IN D5-W
Alcohol anhydrous
Alcohol Anhydrous
Alcohol dehydrated
Alcohol denatured
alcohol etilico
Alcohol etilico
Alcohol etílico
Alcohol, absolute
Alcohol, Absolute
Alcohol, anhydrous
Alcohol, dehydrated
Alcohol, Dehydrated
Alcohol, denatured
Alcohol, diluted
Alcohol, Diluted
Alcohol, ethyl
Alcohol, grain
Alcohol, Grain
Alcohols
Alcohols, C1-3
Alcohols, C30
Alcohols, C6-9
Alcool ethylique
Alcool Ethylique
Alcool éthylique
Alcool etilico
Alcool Etilico
Algrain
Alkohol
Alkohol [German]
Alkoholu etylowego
Alkoholu Etylowego
Aminoethanol
Anhydrol
Anhydrol PM 4085
Anhydrous alcohol
Anhydrous ethanol
Äthanol
Äthylalkohol
Beta-Aminoethanol
Beta-Aminoethyl Alcohol
Beta-Ethanolamine
Beta-Hydroxyethylamine
bmse000297
C00469
C2H5OH
C2H6O
Caswell No. 426
Caswell No. 430
CCRIS 945
CDA 19
CDA 19-200
CHEBI:16236
|
CHEMBL545
CID702
Colamine
Cologne spirit
Cologne Spirit
Cologne spirits
D000431
D00068
DB00898
Dehydrated alcohol
Dehydrated ethanol
Dehydrated Ethanol
Denatured alcohol
Denatured Alcohol
Denatured Alcohol Cd-10
Denatured Alcohol Cd-5
Denatured Alcohol Cd-5a
Denatured Alcohol Sd-1
Denatured Alcohol Sd-13a
Denatured Alcohol Sd-17
Denatured Alcohol Sd-23a
Denatured Alcohol Sd-28
Denatured Alcohol Sd-30
Denatured Alcohol Sd-39b
Denatured Alcohol Sd-39c
Denatured Alcohol Sd-3a
Denatured Alcohol Sd-40m
Denatured ethanol
Denatured Ethanol
Desinfektol el
Desinfektol EL
Diluted alcohol
Distilled spirits
E2385_SIGMA
E7023_ALDRICH
E7023_SIAL
E7148_ALDRICH
E7148_SIAL
E7517_SIGMA
EINECS 200-578-6
EINECS 270-649-4
Envision Conditioner Pdd 9020
EOH
EOX
Esumiru WK 88
ETA
etanol
Etanol
Etanolo
Etanolo [Italian]
ethanol
éthanol
Ethanol (9CI)
Ethanol [JAN]
Ethanol 200 proof
Ethanol 200 Proof
Ethanol Absolute
Ethanol Absolute Bp
Ethanol Anhydrous
Ethanol Extra Pure
Ethanol solution
Ethanol Vapor
Ethanol, Silent Spirit
Ethanol, undenatured
Ethanolum anhydricum
Ethicap
Ethyl alc
ethyl alcohol
Ethyl alcohol
Ethyl Alcohol
Ethyl Alcohol & Water, 10%
Ethyl Alcohol & Water, 20%
Ethyl Alcohol & Water, 30%
Ethyl Alcohol & Water, 40%
Ethyl Alcohol & Water, 5%
Ethyl Alcohol & Water, 50%
Ethyl Alcohol & Water, 60%
Ethyl Alcohol & Water, 70%
Ethyl Alcohol & Water, 80%
Ethyl Alcohol & Water, 95%
Ethyl Alcohol & Water, 96%
Ethyl alcohol anhydrous
Ethyl Alcohol Anhydrous
Ethyl alcohol in alcoholic beverages
Ethyl alcohol usp
Ethyl Alcohol, Anhydrous
Ethyl Alcohol, Denatured
Ethyl hydrate
Ethyl Hydrate
Ethyl hydroxide
Ethyl Hydroxide
Ethylalcohol
Ethylalcohol [Dutch]
Ethylol
Ethylolamine
Ethyloxy Group
EtOH
Etylowy alkohol
FEMA No. 2419
FEMA Number 2419
Fermentation alcohol
Glycinol
grain alcohol
Grain alcohol
Hinetoless
HSDB 531
HSDB 82
Hydroxyethane
HYDROXYETHYL GROUP
I14-12648
IMS 99
Infinity pure
Infinity Pure
Jaysol
Jaysol S
LS-1539
LTBB002977
Lux
Methylated spirit
Methylated Spirit Mineralised
Methylcarbinol
Molasses alcohol
MolPort-001-785-844
NCGC00091458-01
nchem.651-comp3c
nchembio.552-comp10
nchembio.94-comp20
NCI-C03134
NSC 85228
NSC85228
Oxydimethylene Group
potato Alcohol
Potato alcohol
Punctilious ethyl alcohol
Pyro
QMHAIh@
Reagent Alcohol
Ru-Tuss Expectorant
SDA 3A
SDA 40-2
SDM No. 37
Sekundasprit
Silent spirit
Spirit
Spirits of wine
Spirits OF wine
spiritus vini
Spiritus vini
Spirt
SY Fresh M
Synasol
Tecsol
Tecsol C
Thanol
Thiofaco M-50
Undenatured ethanol
UNII-3K9958V90M
USAF EK-1597
WLN: Q2
|
|
7 |
|
Metoprolol |
Approved, Investigational |
Phase 4 |
|
37350-58-6, 51384-51-1 |
4171
|
Synonyms:
(+/-)-metoprolol
(RS)-Metoprolol
1-(Isopropylamino)-3-(4-(2-methoxyethyl)phenoxy)propan-2-ol
1-(Isopropylamino)-3-(p-(2-methoxyethyl)phenoxy)-2-propanol
1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol
1-(isopropylamino)-3-[4-(2-Methoxyethyl)phenoxy]propan-2-ol
1-[(1-methylethyl)amino]-3-({4-[2-(methyloxy)ethyl]phenyl}oxy)propan-2-ol
1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol
1-[4-(2-methoxyethyl)phenoxy]-3-propan-2-ylamino-propan-2-ol
3-[4-(2-methoxyethyl)phenoxy]-1-(propan-2-ylamino)propan-2-ol
37350-58-6
51384-51-1
54163-88-1
AB00053499
AC-19022
AC1L1HKM
AstraZeneca Brand of Metaoprolol Tartrate
AstraZeneca Brand of Seloken
Beatrolol
Beloc
Beloc duriles
Beloc Duriles
Beloc-duriles
BelocDuriles
Beloc-Duriles
Betaloc
Betaloc astra
Betaloc Astra
Betaloc-astra
BetalocAstra
Betaloc-Astra
Betalok
BRD-A03623303-045-02-0
C07202
CCRIS 4198
CGP 2175
CGP2175
CGP-2175
CHEBI:6904
CHEMBL13
CID4171
CR-XL, Metoprolol
D008790
D02358
DB00264
dl-Metoprolol
DL-metoprolol
DL-Metoprolol
Dutoprol
EINECS 253-483-7
EINECS 257-166-4
H 93 26
|
H 9326
H 93-26
HMS2090B15
HSDB 6531
I01-7125
I06-0125
Jsp006606
L000669
Leiras Brand of Metoprolol Succinate or Metoprolol Tartrate
Lopresor
Lopresoretic
LOPRESSIDONE
Lopressor
Lopressor HCT
LS-122450
Meijoprolol
Metohexal
metoprolol
Metoprolol (USAN/INN)
Metoprolol [USAN:INN:BAN]
Metoprolol CR XL
Metoprolol CR-XL
Metoprolol succinate
Metoprolol tartrate
Metoprolol Tartrate
Metoprololum
Metoprololum [INN-Latin]
Metroprolol
MolPort-005-938-039
NCGC00021148-02
NCGC00021148-03
NCGC00021148-04
Novartis Brand of Metprolol Tartrate
Preblok
Prelis
Presolol
Seloken
Seloken AstraZeneca Brand
Selopral
Selo-Zok
Seroken
Spesicor
Spesikor
Succinate, metoprolol
Tartrate, metoprolol
Tartrate, Metoprolol
Toprol
Toprol XL
ToprolXL
Toprol-XL
TOPROL-XL
UNII-GEB06NHM23
|
|
8 |
|
Cytochrome P-450 CYP1A2 Inhibitors |
|
Phase 4,Phase 3 |
|
|
|
9 |
|
Cytochrome P-450 Enzyme Inhibitors |
|
Phase 4,Phase 3 |
|
|
|
10 |
|
Sodium Channel Blockers |
|
Phase 4 |
|
|
|
11 |
|
Adrenergic Agents |
|
Phase 4 |
|
|
|
12 |
|
Cytochrome P-450 CYP2C9 Inhibitors |
|
Phase 4 |
|
|
|
13 |
|
Diuretics, Potassium Sparing |
|
Phase 4 |
|
|
|
14 |
|
Autonomic Agents |
|
Phase 4 |
|
|
|
15 |
|
Anti-Arrhythmia Agents |
|
Phase 4,Not Applicable |
|
|
|
16 |
|
Adrenergic beta-Antagonists |
|
Phase 4 |
|
|
|
17 |
|
Cytochrome P-450 CYP2D6 Inhibitors |
|
Phase 4 |
|
|
|
18 |
|
Peripheral Nervous System Agents |
|
Phase 4 |
|
|
|
19 |
|
Potassium Channel Blockers |
|
Phase 4 |
|
|
|
20 |
|
Neurotransmitter Agents |
|
Phase 4 |
|
|
|
21 |
|
Cytochrome P-450 CYP3A Inhibitors |
|
Phase 4 |
|
|
|
22 |
|
Vasodilator Agents |
|
Phase 4 |
|
|
|
23 |
|
Sympatholytics |
|
Phase 4 |
|
|
|
24 |
|
Adrenergic Antagonists |
|
Phase 4 |
|
|
|
25 |
|
Antihypertensive Agents |
|
Phase 4,Not Applicable |
|
|
|
26 |
|
Adrenergic beta-Agonists |
|
Phase 4 |
|
|
|
27 |
|
Adrenergic beta-1 Receptor Antagonists |
|
Phase 4 |
|
|
|
28 |
|
Adrenergic Agonists |
|
Phase 4 |
|
|
|
29 |
|
Clindamycin |
Approved, Vet_approved |
Phase 3 |
|
18323-44-9 |
29029
|
Synonyms:
13441-63-9
16669-21-9
18323-44-9
21462-39-5 (mono-hydrochloride)
24620-78-8
24696-19-3
58207-19-5
7 chloro 7 Deoxylincomycin
7(S)-chloro-7-Deoxylincomycin
7(S)-Chloro-7-deoxylincomycin
7-CDL
7-chloro-7-Deoxylincomycin
7-Chloro-7-deoxylincomycin
7-Chlorolincomycin
7-Deoxy-7(S)-chlorolincomycin
AC1L1EGQ
AC1L1GLA
AC1L9JV8
AC1MHD7N
AC1MHE1M
AC1MHUOE
AC1MHX4G
AC1NWAKO
AC1O7ENS
AC1O7GED
AC1OFCIP
AC1OFCIV
AC1OFCJ1
AC1OFCJ7
AC1OIBYJ
AC1OIBYL
AC1OIBYN
AC1Q2V4O
Antirobe
BIDD:GT0418
BPBio1_000236
BRD-A23034328-003-03-4
BSPBio_000214
BSPBio_002049
C06914
C18H33ClN2O5S
CAS-21462-39-5
CHEBI:3745
CHEMBL187
Chlolincocin
Chlorlincocin
Chlorodeoxylincomycin
Chlorolincomycin
CID2786
CID29029
CID3000512
CID3001928
CID3032758
CID3034218
CID446598
CID5702026
CID6602476
CID6604361
CID7048642
CID7048644
CID7048646
CID7048648
CID7276014
CID7276016
CID7276018
CID9812677
CLDM
Cleocin
Cleocin (tn)
Cleocin (TN)
Cleocin Hcl
Cleocin HCl
Cleocin Pediatric
Cleocin Phosphate
Cleocin T
Cleocin T Gel
Cleocin T Lotion
Cleocin T Topical Solution
CLINDA & IL-12
ClindaDerm
Clinda-Derm
Clindagel
Clindamicina
Clindamicina [INN-Spanish]
clindamycin
|
Clindamycin
Clindamycin & Interleukin 12
Clindamycin & VRC3375
Clindamycin (USAN/INN)
Clindamycin [USAN:BAN:INN]
Clindamycin Hcl
Clindamycin hydrochloride
Clindamycin Hydrochloride
Clindamycin monohydrochloride
Clindamycin monohydrochloride, monohydrate
Clindamycin phosphate
Clindamycin Phosphate
Clindamycine
Clindamycine [French]
Clindamycine [INN-French]
Clindamycinum
Clindamycinum [INN-Latin]
Clindesse
Clindets
Clinimycin
CLY
D00277
Dalacin
Dalacin C
Dalacin C Flavored Granules
Dalacin C Phosphate
Dalacin T Topical Solution
Dalacine
DB01190
DivK1c_000464
EINECS 242-209-1
Evoclin
HMS2089A05
HMS2089N16
HSDB 3037
Hydrochloride, clindamycin
I06-0826
IDI1_000464
KBio1_000464
KBio2_000638
KBio2_003206
KBio2_005774
KBio3_001269
KBioGR_000844
KBioSS_000638
Klimicin
Klindan 300
LS-187128
LS-98131
Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-a-D-galacto-octopyranoside
Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside
Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-α-D-galacto-octopyranoside
MLS001183714
MolPort-002-323-206
MolPort-002-964-479
Monohydrate clindamycin monohydrochloride
Monohydrochloride, clindamycin
Monohydrochloride, monohydrate clindamycin
NCGC00016752-01
NCGC00178843-01
NCGC00179636-01
NINDS_000464
Prestwick0_000137
Prestwick1_000137
Prestwick2_000137
Prestwick3_000137
ResiDerm A
SMP2_000295
SMR000677917
Sobelin
SPBio_000670
SPBio_002153
Spectrum_000158
Spectrum2_000885
Spectrum3_000355
Spectrum4_000292
Spectrum5_001525
STK177246
STOCK1N-31150
U 21251
U-21,251
U-21251
UNII-3U02EL437C
Zindaclin
|
|
30 |
|
Levofloxacin |
Approved, Investigational |
Phase 3 |
|
100986-85-4 |
149096
|
Synonyms:
(−
(-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(-)-(S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7Hpyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hemihydrate
(-)-(S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyridol[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hemihydrate
(-)-Ofloxacin
(3S)-(-)-9-fluoro-3-Methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylate
(3S)-(-)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid
(3S)-(-)-9-fluoro-3-Methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid
(3S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
(R)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(R)-isomer
(S)-(-)-9-fluoro-3-Methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzooxazine-6-carboxylate
(S)-(-)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzooxazine-6-carboxylic acid
(S)-(-)-9-fluoro-3-Methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzooxazine-6-carboxylic acid
(S)-(-)-Ofloxacin
(S)-9-fluoro-2,3-dihydro-3-Methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylate
(S)-9-fluoro-2,3-dihydro-3-Methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(S)-Ofloxacin
)-Ofloxacin
100986-85-4
100986-86-5
28266_FLUKA
28266_SIGMA
AC1L3YF8
AC-7593
Aeroquin
Ambap100986-85-4
Anhydrous, levofloxacin
BRD-K09471561-001-06-7
BSPBio_002689
C07660
C18H20FN3O4
C18H20FN3O4.H2O
CCRIS 4073
CCRIS 4074
CHEMBL33
CID149096
CPD000466387
Cravit
Cravit (TN)
Cravit Ophthalmic
D08120
DB01137
d-Levofloxacin
DR 3354
DR3355
DR-3355
DR-3355: L-isomer of ofloxacin
Elequine
Floxacin
Floxel
Floxin
HMS1922J07
HMS2051G04
HMS2090O10
HMS2093E18
HR 355
HR-355
Iquix
KBio2_002199
|
KBio2_004767
KBio2_007335
KBio3_001909
KBioGR_001605
KBioSS_002199
L0193
Leroxacin
Lesacin
Levaquin
LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER
LEVOFLOXACIN
Levofloxacin (INN)
Levofloxacin [USAN:INN:JAN]
Levofloxacin anhydrous
Levofloxacin hydrate
Levofloxacin tablet, suspension or intravenous
Levofloxacine
Levofloxacine [INN-French]
Levofloxacino
Levofloxacino [INN-Spanish]
Levofloxacinum
Levofloxacinum [INN-Latin]
Levokacin
Levox
Levoxacin
LFX
L-Ofloxacin
LS-133260
LS-171761
LVX
MLS000759524
MLS001165709
MLS001423977
MolPort-002-885-835
Mosardal
MP-376
NCGC00178529-01
Nofaxin
Ofloxacin
Ofloxacin S-(-)-form
Ofloxacin, (S)-isomer
Oftaquix
Quixin
Reskuin
R-Ofloxacin
RWJ 25213-097
RWJ-25213
S-(-)-Ofloxacin
S1940_Selleck
SAM001246758
SMR000466387
SPBio_001891
Spectrum_001719
SPECTRUM1504260
Spectrum2_001676
Spectrum3_000995
Spectrum4_001123
Spectrum5_001438
Tavanic
Volequin
|
|
31 |
|
Ofloxacin |
Approved |
Phase 3 |
|
82419-36-1 |
4583
|
Synonyms:
( -)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)(1,4)benzoxazin-6-carbonsaeure
(+-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(+/-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperaz inyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(+/-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7- -oxo-7H-pyrido(1,2,3-de)- -1,4-benzoxazine-6-carboxylic acid
(+/-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
(+/-)-Floxin
118120-51-7 (hydrochloride)
33703_FLUKA
33703_RIEDEL
82419-36-1
83380-47-6
85344-55-4
8-fluoro-3-Methyl-9-(4-methyl-piperazin-1-yl)-6-oxo-2,3-dihydro-6H-1-oxa-3a-aza-phenalene-5-carboxylate
8-fluoro-3-Methyl-9-(4-methyl-piperazin-1-yl)-6-oxo-2,3-dihydro-6H-1-oxa-3a-aza-phenalene-5-carboxylic acid
8-Fluoro-3-methyl-9-(4-methyl-piperazin-1-yl)-6-oxo-2,3-dihydro-6H-1-oxa-3a-aza-phenalene-5-carboxylic acid
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
AB00513820
AC1L1IHM
AC-7616
AKOS001033517
Bactocin
BB_SC-1252
BPBio1_000345
BRD-A24228527-001-05-9
BRN 3657947
BSPBio_000313
BSPBio_003117
C07321
C18H20FN3O4
CCRIS 5233
CHEBI:7731
CHEMBL4
CID4583
CPD000058192
D00453
Danoflox
DB01165
DEXTROFLOXACINE
DivK1c_000721
DL 8280
DL-8280
DL-8280, HOE-280, Exocin, Flobacin, Floxin, Floxil, Monoflocet, Ofloxacin
Effexin
EU-0100904
Exocin
Exocine
Flobacin
Flodemex
Flotavid
Flovid
Floxal
Floxil
Floxin
Floxin (TN)
FLOXIN IN DEXTROSE 5%
FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Floxin otic
Floxstat
Fugacin
HMS1568P15
HMS1921H12
HMS2090F07
HMS2092B10
HMS502E03
Hoe 280
HOE 280
Hoe-280
I06-0112
I06-0380
IDI1_000721
Inoflox
KBio1_000721
KBio2_001666
KBio2_004234
KBio2_006802
KBio3_002617
KBioGR_000667
KBioSS_001666
Kinflocin
Kinoxacin
Liflox
Lopac0_000904
Loxinter
LS-133259
Marfloxacin
Medofloxine
Mergexin
MLS000028749
MLS001074203
MolPort-000-422-241
MolPort-000-873-068
NCGC00015772-02
NCGC00015772-10
|
NCGC00094219-01
NCGC00094219-02
NCGC00094219-03
NCGC00094219-04
NCGC00094219-05
NCGC00094219-06
NCGC00178284-01
NCGC00178284-02
NINDS_000721
Novecin
NSC727071
Nufafloqo
O 8757
O8757_SIGMA
Obide
Occidal
Ocuflox
Ofcin
Oflin
Oflocee
Oflocet
Oflocin
Oflodal
Oflodex
Oflodura
Oflox
O-Flox
ofloxacin
Ofloxacin (JP15/USP/INN)
Ofloxacin [USAN:BAN:INN:JAN]
Ofloxacin hydrochloride
Ofloxacin Otic
Ofloxacin, (S)-Isomer
Ofloxacina
Ofloxacina [DCIT]
Ofloxacine
Ofloxacine [French]
Ofloxacino
Ofloxacino [Spanish]
Ofloxacinum
Ofloxacinum [Latin]
Ofloxin
OFLX
Ofus
OFX
Onexacin
Operan
Oprea1_242882
ORF 18489
ORF-28489
Orocin
Otonil
Oxaldin
Pharflox
Praxin
Prestwick0_000237
Prestwick1_000237
Prestwick2_000237
Prestwick3_000237
PT 01
Puiritol
Qinolon
Qipro
Quinolon
Quotavil
Rilox
Ru-43280
S1463_Selleck
SAM002264629
Sinflo
SMR000058192
SPBio_001387
SPBio_002234
Spectrum_001186
SPECTRUM1502044
Spectrum2_001464
Spectrum3_001499
Spectrum4_000324
Spectrum5_001063
STK256723
Tabrin
Taravid
Tariflox
Tarivid
Telbit
Tructum
UNII-A4P49JAZ9H
Uro Tarivid
Viotisone
Visiren
WP-0405
XED
Zanocin
|
|
32 |
|
Bacitracin |
Approved, Vet_approved |
Phase 3 |
|
1405-87-4 |
10909430
439542
|
Synonyms:
(4R)-4-[[(2S)-2-[[(4R)-2-[(1S,2S)-1-amino-2-methylbutyl]-4,5-dihydro-1,3-thiazole-4-carbonyl]amino]-4-methylpentanoyl]amino]-5-[[(2S,3S)-1-[[(3S,6R,9S,12R,15R,18R,21S)-3-(2-amino-2-oxoethyl)-18-(3-aminopropyl)-12-benzyl-15-[(2S)-butan-2-yl]-6-(carboxymethyl)-9-(1H-imidazol-5-ylmethyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclopentacos-21-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-5-oxopentanoic acid
(4R)-4-[[(2S)-2-[[2-(1-amino-2-methylbutyl)-4,5-dihydro-1,3-thiazole-4-carbonyl]amino]-4-methylpentanoyl]amino]-5-[[(2S,3S)-1-[[(3S,6R,9S,12R,15S,18R,21S)-3-(2-amino-2-oxoethyl)-18-(3-aminopropyl)-12-benzyl-15-[(2S)-butan-2-yl]-6-(carboxymethyl)-9-(1H-imidazol-5-ylmethyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclopentacos-21-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-5-oxopentanoic acid
11702_FLUKA
11702_SIGMA
22601-59-8
4-[[2-[[2-(1-amino-2-methylbutyl)-4,5-dihydro-1,3-thiazole-4-carbonyl]amino]-4-methylpentanoyl]amino]-5-[[1-[[3-(2-amino-2-oxoethyl)-18-(3-aminopropyl)-12-benzyl-15-butan-2-yl-6-(carboxymethyl)-9-(1H-imidazol-5-ylmethyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclopentacos-21-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-5-oxopentanoic acid
46084_RIEDEL
A.L. labs brand OF bacitracin zinc salt
AB00513964
AC1L22YV
AC1O6F67
AC1O8Q0J
AC1Q6GKZ
Ak tracin
Akorn brand OF bacitracin
Ak-tracin
Altracin
B0125_SIGMA
Baci im
Baci RX
Baciguent
Baci-im
Baciquent
Baci-RX
Bacitin
bacitracin
Bacitracin a
Bacitracin A
Bacitracin A1
Bacitracin a2a
Bacitracin A2a
Bacitracin akorn brand
Bacitracin dioptic brand
Bacitracin lee brand
Bacitracin mcneil brand
Bacitracin pharmascience brand
Bacitracin zinc
Bacitracin zinc complex
Bacitracin, zinc
Bacitracine martinet
BPBio1_000878
BSPBio_000798
|
C15482
CHEMBL1200558
Ciba vision brand OF bacitracin
CID10909430
CID6474109
CID65281
CID6714010
Citracin
Dioptic brand OF bacitracin
EINECS 245-115-9
Fortracin
HMS1570H20
L-Asparagine, N-[[(4R)-2-[(1S,2S)-1-amino-2-methylbutyl]-4,5-dihydro-4-thiazolyl]carbonyl]-L-leucyl-D-.alpha.-glutamyl-L-isoleucyl-L-lysyl-D-ornithyl-L-isoleucyl-D-phenylalanyl-L-histidyl-D-.alpha.-as
Lee brand OF bacitracin
LS-23608
Martinet, bacitracine
McNeil brand OF bacitracin
MLS002695992
MolPort-003-926-019
n-{[2-(1-amino-2-methylbutyl)-4,5-dihydro-1,3-thiazol-4-yl]carbonyl}leucyl-|A-glutamyl-n-[3-(2-amino-2-oxoethyl)-18-(3-aminopropyl)-12-benzyl-15-(butan-2-yl)-6-(carboxymethyl)-9-(1h-imidazol-5-ylmethyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptaazacyclopentacosan-21-yl]isoleucinamide
NSC 45737
Ocu tracin
Ocumed brand OF bacitracin
Ocu-tracin
OcuTracin
partyl-, (10.4)-lactam
Pharma tek brand OF bacitracin
Pharmascience brand OF bacitracin
Prestwick1_000919
Prestwick2_000919
Prestwick3_000919
Reed and carnrick brand OF bacitracin
SMR001562136
Solu-Tracin 50
SPBio_002987
Topitracin
UNII-DDA3RRX0P7
Zeba RX
Zeba-RX
Zinc bacitracin
Zinc, bacitracin
|
|
33 |
|
Cephalexin |
Approved, Investigational, Vet_approved |
Phase 3 |
|
15686-71-2 |
27447
|
Synonyms:
(6R,7R)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7R)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
105879-42-3 (mono-hydrochloride, mono-hydrate)
105879-42-3 (mono-hydrochloride,mono-hydrate)
14101-75-8
15686-71-2
15686-71-2 (Parent)
17692-47-6
23325-78-2
23325-78-2 (mono-hydrate)
38932-40-0 (mono-hydrochloride salt)
66905-57-5 (di-hydrate)
7-(D-2-Amino-2-phenylacetamido)-3-methyl-delta (sup 3)-cephem-4- carboxylic acid
7-(D-2-Amino-2-phenylacetamido)-3-methyl-delta3-cephem-4-carboxylic acid
7-(D-a-aminophenylacetamido)Desacetoxycephalosporanate
7-(D-a-aminophenylacetamido)Desacetoxycephalosporanic acid
7-(D-alpha-aminophenylacetamido)Desacetoxycephalosporanate
7-(D-alpha-aminophenylacetamido)Desacetoxycephalosporanic acid
7-(D-alpha-Aminophenylacetamido)desacetoxycephalosporanic acid
7-(D-α-aminophenylacetamido)desacetoxycephalosporanate
7-(D-α-aminophenylacetamido)desacetoxycephalosporanic acid
7-b-(D-a-amino-a-phenylacetylamino)-3-Methyl-3-cephem-4-carboxylate
7-b-(D-a-amino-a-phenylacetylamino)-3-Methyl-3-cephem-4-carboxylic acid
7-beta-(D-alpha-amino-alpha-phenylacetylamino)-3-Methyl-3-cephem-4-carboxylate
7-beta-(D-alpha-amino-alpha-phenylacetylamino)-3-Methyl-3-cephem-4-carboxylic acid
7-beta-(D-alpha-Amino-alpha-phenylacetylamino)-3-methyl-3-cephem-4-carboxylic acid
7-β-(D-α-amino-α-phenylacetylamino)-3-methyl-3-cephem-4-carboxylate
7-β-(D-α-amino-α-phenylacetylamino)-3-methyl-3-cephem-4-carboxylic acid
AC1L1D8M
AC1L1Y1M
AC1O6OSE
Adcadina
Ades[prex
AKOS004119846
Alcephin
Alexin
Alsporin
Ambal
Anhydrous cefalexin
Anhydrous cephalexin
Aristosporin
Azabort
Bactopenor
BB_NC-1052
Beliam
Biocef
BPBio1_000501
BRD-K90733503-002-03-6
BRN 0965503
BSPBio_000455
C06895
C08099
C16H17N3O4S
Carnosporin
Cefablan
Cefacet
Cefadal
Cefadin
Cefadina
Cefa-iskia
Cefalekey
Cefaleksin
Cefalessina
Cefalessina [DCIT]
Cefalexgobens
Cefalexin
Cefalexin (JP15)
Cefalexin anhydrous
Cefalexin generics
cefalexin hydrate
cefalexin monohydrate
Cefalexin Scand Pharm
Cefalexin Sodium
cefalexin.H2O
Cefalexina
Cefalexina [INN-Spanish]
Cefalexina Northia
Cefalexina Richet
Cefalexine
Céfalexine
Cefalexine [INN-French]
Cefalexinum
Cefalexinum [INN-Latin]
Cefalin
Cefalival
Cefaloto
Cefaseptin
Cefax
Ceffanex
Cefibacter
Ceflax
Ceforal
Cefovit
Celexin
Cepastar
Cepexin
Cephacillin
Cephalex von ct
cephalexin
Cephalexin (anhydrous)
Cephalexin (USP)
Cephalexin [USAN:BAN]
Cephalexin 1-hydrate
Cephalexin 1-wasser
Cephalexin anhydrous
Cephalexin dihydride
Cephalexin hemihydrate
Cephalexin hydrate
Cephalexin hydrochloride
Cephalexin monohydrate
Cephalexin monohydrochloride
Cephalexin monohydrochloride, monohydrate
Cephalexin, (6R-(6alpha,7alpha(r*)))-isomer
Cephalexin, (6R-(6alpha,7beta(s*)))-isomer
Cephalexin, (6R-(6alpha,7beta))-isomer
Cephalexin, (6R-(6alpha,7beta))-Isomer
Cephalexin, monosodium salt
Cephalexin, monosodium salt, (6R-(6alpha,7beta))-isomer
cephalexin.H2O
Cephalexine
Cephalexinum
Cephalobene
Cephanasten
Cephaxin
Cephin
Cepol
Ceporex
Ceporex Forte
Ceporexin
Ceporexine
Ceporexin-E
CEX
CHEBI:3534
|
CHEBI:3535
Check
CHEMBL1200544
CHEMBL1727
CID27447
CID62921
CID6560168
Cophalexin
CPD000338536
CPD-9227
Cusisporina-Cefalox
D00263
D00906
DB00567
Dihydride, cephalexin
Domucef
Doriman
Durantel
Durantel DS
Ed A-Ceph
Efemida
EINECS 239-773-6
Erocetin
Factagard
Felexin
Fexin
Hemihydrate, cephalexin
Henina Oral
HMS1569G17
HMS2051A04
HSDB 3022
Hydrochloride, cephalexin
Ibilex
Ibrexin
Inphalex
Karilexina
Kefalospes
Keflet
Keflex
Keflex (TN)
Kefolan
Keforal
Keftab
Keftab (TN)
Kekrinal
Kidolex
KS-1134
Lafarine
Larixin
Lenocef
Lexibiotico
Lilly 66873
L-Keflex
Loisine
Lonflex
Lopilexin
Losporal
LS-149963
LS-173992
LS-174191
Madlexin
Maksipor
Mamalexin
Mamlexin
Medolexin
Medoxine
MLS000759527
MolPort-002-507-304
MolPort-006-823-789
Monohydrate cephalexin monohydrochloride
Monohydrate, cephalexin
Monohydrochloride, cephalexin
Monohydrochloride, monohydrate cephalexin
Monosodium salt cephalexin
NCGC00159522-02
NCGC00159522-03
Neokef
Neolexina
Noveol
Novolexin
Nufex
Oracef
Oriphex
Oroxin
Ortisporina
Ospexin
Palitrex
Panixine Disperdose
Panixine disperdose (TN)
Pectril
Prestwick_750
Prestwick0_000358
Prestwick1_000358
Prestwick2_000358
Prestwick3_000358
Prindex
Pyassan
Rilexine
Roceph
Roceph Distab
Rogevil
S 6437
SAM001246761
Sanaxin
Sartosona
Sencephalin
Sepexin
Servicef
Servispor
Sialexin
Sinthecillin
Sintolexyn
SMR000338536
SPBio_002376
Sporicef
Sporidex
SQ 20248
Syncl
Syncle
Synecl
Tepaxin
Theratrex
Tokiolexin
UNII-5SFF1W6677
UNII-OBN7UDS42Y
Uphalexin
Viosporine
Voxxim
Winlex
Zabytrex
ZINC01530596
ZINC03830500
Zozarine
|
|
34 |
|
Topoisomerase Inhibitors |
|
Phase 3 |
|
|
|
35 |
|
Polymyxins |
|
Phase 3 |
|
|
|
36 |
|
Anti-Bacterial Agents |
|
Phase 3 |
|
|
|
37 |
|
Anti-Infective Agents, Local |
|
Phase 3 |
|
|
|
38 |
|
Renal Agents |
|
Phase 3 |
|
|
|
39 |
|
Anti-Infective Agents |
|
Phase 3 |
|
|
|
40 |
|
Clindamycin palmitate |
|
Phase 3 |
|
|
|
41 |
|
Clindamycin phosphate |
|
Phase 3 |
|
|
|
42 |
|
Polymyxin B |
|
Phase 3 |
|
|
|
43 |
|
Antibiotics, Antitubercular |
|
Phase 3 |
|
|
|
44 |
|
Anti-Infective Agents, Urinary |
|
Phase 3 |
|
|
|
45 |
|
Antitubercular Agents |
|
Phase 3 |
|
|
|
46 |
|
Angiotensin II |
Approved, Investigational |
,Not Applicable |
|
11128-99-7, 68521-88-0, 4474-91-3 |
172198
65143
|
Synonyms:
1-8-Angiotensin I
1-L-Aspasaginyl-5-L-valyl angiotensin octapeptide
5 L Isoleucine angiotensin II
5-isoleucine-angiotensin II
5-Isoleucine-angiotensin II
5-L-Isoleucine angiotensin II
5-L-isoleucineangiotensin II
5-L-Isoleucineangiotensin II
Ang II
ANG-(1-8)octapeptide
Angiotensin
Angiotensin 2
Angiotensin II (human)
Angiotensin II (mouse)
Angiotensin II, 5-L-isoleucine
Angiotensin-(1-8) octapeptide
|
Angiotonin
Asp-arg-val-tyr-ile-his-pro-phe
Human angiotensin II
Hypertensin
II, 5-L-isoleucine angiotensin
Ile(5)-angiotensin II
Ile5-angiotensin II
Isoleucine(5)-angiotensin
Isoleucine(5)-angiotensin II
isoleucine5-angiotensin II
Isoleucyl(5)-angiotensin II
N-(1-(N-(N-(N-(N-(N(2)-L-a-Aspartyl-L-arginyl)-L-valyl)-L-tyrosyl)-L-isoleucyl)-L-histidyl)-L-prolyl)-L-phenylalanine
N-(1-(N-(N-(N-(N-(N(2)-L-alpha-Aspartyl-L-arginyl)-L-valyl)-L-tyrosyl)-L-isoleucyl)-L-histidyl)-L-prolyl)-L-phenylalanine
N-(1-(N-(N-(N-(N-(N(2)-L-α-aspartyl-L-arginyl)-L-valyl)-L-tyrosyl)-L-isoleucyl)-L-histidyl)-L-prolyl)-L-phenylalanine
Valyl(5)-angiotensin II
|
|
47 |
|
Losartan |
Approved |
Not Applicable |
|
114798-26-4 |
3961
|
Synonyms:
(2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-imidazol-5-yl)methanol
(2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol
(2-Butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol
[2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol
114798-26-4
124750-99-8 (mono-potassium salt)
1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- (9CI)
2-Butyl-4-chloro-1-((2'-(1H-etrazol-5-yl) (1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-methanol
2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl-1H-imidazole-5-methanol
2-butyl-4-chloro-1-[p-(o-1H-tetrazol-5ylphenyl)benzyl]imidazole-5-methanol
2-n-butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole
2-N-Butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole
2-n-butyl-4-chloro-5-hydroxymethyl-1-[[2'-(1H-tetrazol-5-yl)-biphenyl-4-yl]methyl]imidazole
AC1L1H3Q
BIDD:GT0286
BRD-K76205745-001-02-5
BSPBio_002695
C07072
C22H23ClN6O
CHEBI:6541
CHEMBL191
CID3961
CL23623
Cozaar
D08146
DB00678
DuP 753
DuP 89
DUP 89
DuP-753
HMS1922J13
HMS2093E22
Hyzaar
I14-9710
Jsp001094
KBio2_002193
KBio2_004761
|
KBio2_007329
KBio3_001915
KBioGR_001611
KBioSS_002193
L000351
Lacidipine
Lortaan
losartan
Losartan
Losartan (INN)
Losartan [INN:BAN]
Losartan monopotassium salt
losartan potassium
Losartan potassium
LOSARTAN POTASSIUM
Losartic
Losartic (TN)
LS-78746
MK954
MK-954
MolPort-003-666-553
Monopotassium salt, losartan
NCGC00095125-01
NCGC00095125-02
NCGC00095125-03
Oprea1_644635
Potassium, losartan
Salt, losartan monopotassium
SPBio_001893
Spectrum_001713
SPECTRUM1504268
Spectrum2_001677
Spectrum3_000998
Spectrum4_001126
Spectrum5_001466
UNII-JMS50MPO89
|
|
48 |
|
tannic acid |
Approved |
Not Applicable |
|
|
|
49 |
|
Benzocaine |
Approved, Investigational |
Not Applicable |
|
94-09-7, 1994-09-7 |
2337
|
Synonyms:
(P-(Ethoxycarbonyl)phenylamine
06952_FLUKA
112909_ALDRICH
112909_SIAL
1333-08-0
23239-88-5
23239-88-5 (hydrochloride)
4 Aminobenzoic Acid Ethyl Ester
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-14-00-01129 (Beilstein Handbook Reference)
4-Aminobenzoate
4-Aminobenzoate ethyl ester
4-Aminobenzoic acid
4-aminobenzoic acid ethyl ester
4-amino-benzoic acid ethyl ester
4-Aminobenzoic acid ethyl ester
4-Aminobenzoic acid, ethyl ester
4-Carbethoxyaniline
71123-91-6
94-09-7
94-09-7 (Parent)
A0271
AB00051923
AC1L1DGC
AC1Q341A
AC1Q64JE
Acetate, benzocaine
Acetate, Benzocaine
AE-562/40377256
Aethoform
Aethylium paraminobenzoicum
AI3-02081
AKOS000119763
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthesinum
Anaesthin
Anestezin
Anestezin [Russian]
Anesthesin
Anesthesine
Anesthone
AR-1H9065
Baby anbesol
Baby Anbesol
BB_SC-0019
Bensokain
Benzoak
Benzocaina
Benzocaina [INN-Spanish]
benzocaine
Benzocaine
Benzocaine (USP/INN)
Benzocaine [INN:BAN]
Benzocaine acetate
Benzocaine Acetate
Benzocaine formate
Benzocaine Formate
Benzocaine hydrobromide
Benzocaine Hydrobromide
Benzocaine hydrochloride
Benzocaine Hydrochloride
Benzocaine methanesulfonate
Benzocaine Methanesulfonate
Benzocainum
Benzocainum [INN-Latin]
Benzoic acid, 4-amino-, ethyl ester
Benzoic acid, 4-amino-, ethyl ester, hydrochloride
Benzoic acid, amino-, ethyl ester
Benzoic acid, p-amino-, ethyl ester
BPBio1_001017
BRD-K75466013-001-05-2
BRN 0638434
BSPBio_000923
BSPBio_001908
C07527
CAS-94-09-7
Caswell No. 430A
CHEBI:116735
CHEMBL278172
Chloraseptic
CID2337
D001566
D00552
DB01086
Dermoplast
Diet ayds
DivK1c_000932
E1501_SIGMA
EINECS 202-303-5
EPA Pesticide Chemical Code 097001
Ethoform
Ethoforme
Ethyl 4-aminobenzoate
Ethyl 4-aminobenzoate hydrochloride
Ethyl 4-aminobenzoic acid
Ethyl aminobenzoate
Ethyl Aminobenzoate
Ethyl aminobenzoate (JP15)
Ethyl aminobenzoate (VAN)
Ethyl aminobenzoic acid
|
Ethyl PABA
Ethyl P-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-Aminobenzoate
Ethyl P-aminobenzoate
Ethyl P-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethyl p-Aminophenylcarboxylate
Ethyl P-aminophenylcarboxylate
Ethyl P-aminophenylcarboxylic acid
ethylaminobenzoate-4
Ethylester kyseliny p-aminobenzoove
Ethylester kyseliny P-aminobenzoove
Ethylester kyseliny p-aminobenzoove [Czech]
Ethylis aminobenzoas
ETHYL-P-AMINOBENZOATE
Formate, benzocaine
Formate, Benzocaine
h-4-abz-oet
HMS1570O05
HMS1920G09
HMS2091M11
HMS502O14
HSDB 7225
Hurricaine
Hydrobromide, benzocaine
Hydrobromide, Benzocaine
Hydrochloride, benzocaine
Hydrochloride, Benzocaine
I05-0204
Identhesin
IDI1_000932
KBio1_000932
KBio2_000474
KBio2_003042
KBio2_005610
KBio3_001408
KBioGR_000658
KBioSS_000474
Keloform
LS-35847
Methanesulfonate, benzocaine
Methanesulfonate, Benzocaine
MLS001331704
MLS002153970
MolPort-000-871-526
NCGC00016352-01
NCGC00094598-01
NCGC00094598-02
nchembio.182-comp4
NINDS_000932
Norcain
Norcaine
Norcainum
NSC 122792
NSC 41531
NSC41531
NSC4688
Oprea1_750694
Oprea1_827402
Orabase-b
Ora-jel
Orthesin
Otocain
Outgro
p-(Ethoxycarbonyl)aniline
P-(Ethoxycarbonyl)aniline
P-Aminobenzoate
P-Aminobenzoic acid
p-Aminobenzoic acid ethyl ester
P-Aminobenzoic acid ethyl ester
p-Aminobenzoic acid, ethyl ester
p-Aminobenzoic ethyl ester
Parathesin
Parathesin (TN)
Parathesine
p-Carbethoxyaniline
P-Carbethoxyaniline
p-Ethoxycarboxylic aniline
p-Ethoxycarboxylic Aniline
P-Ethoxycarboxylic aniline
Prestwick_991
Prestwick0_000712
Prestwick1_000712
Prestwick2_000712
Prestwick3_000712
Slim mint gum
SMR000059025
Solarcaine
Solu H
SPBio_000134
SPBio_002844
Spectrum_000074
SPECTRUM1500139
Spectrum2_000117
Spectrum3_000314
Spectrum4_000249
Spectrum5_000860
STK043620
Topcaine
UNII-U3RSY48JW5
WLN: ZR DVO2
ZINC12358719
|
|
50 |
|
Digoxin |
Approved |
|
|
20830-75-5 |
30322
2724385
|
Synonyms:
(3beta,5beta,12beta)-3-{[2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide
0B9662A7-264E-4ACD-94B2-9E1138C0CA5A
12beta-Hydroxydigitoxin
12b-Hydroxydigitoxin
12β-hydroxydigitoxin
20830-75-5
3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S,6R)-5-[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one
4-[(1S,2S,5S,7R,10R,11S,14R,15S,16R)-5-{[(2R,4S,5S,6R)-5-{[(2S,4S,5S,6R)-5-{[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-11,16-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^
4-[(3S,5R,8R,9S,10S,12R,13S,14S)-3-[(2S,4S,5R,6R)-5-[(2S,4S,5R,6R)-5-[(2S,4S,5R,6R)-4,5-dihydroxy-6-methyl-oxan-2-yl]oxy-4-hydroxy-6-methyl-oxan-2-yl]oxy-4-hydroxy-6-methyl-oxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-5H-furan-2-one
AC1MC4TN
AC1Q29PT
AWD.pharma brand OF digoxin
Bertek brand OF digoxin
BIDD:PXR0148
Boehringer, digoxina
BPBio1_000500
BRD-K23478508-001-03-7
BSPBio_000454
C06956
Cardoxin
CHEBI:4551
CHEMBL1751
CID2724385
Cogoxin
Cordioxil
D00298
D1828
D6003_FLUKA
D6003_SIGMA
D6770_SIGMA
Davoxin
Digacin
Digazolan
Digitalis glycoside
Digitalis Glycoside
Digitek
Digitekt
Digoregen
Digossina
digoxin
Digoxin
Digoxin (JP15/USP)
Digoxin pediatric
Digoxin Pediatric
Digoxina
Digoxina boehringer
Digoxine
Digoxine nativelle
Digoxinum
Dilanacin
Dixina
Dokim
Dynamos
Eudigox
glaxo Wellcome brand OF digoxin
GlaxoSmithKline brand 1 OF digoxin
GlaxoSmithKline brand 2 OF digoxin
|
Hemigoxine nativelle
HMS1569G16
Homolle's Digitalin
Homolle'S digitalin
Kern brand OF digoxin
Lanacordin
Lanacrist
Lanadicor
Lanicor
Lanoxicaps
Lanoxicaps (TN)
Lanoxin
Lanoxin (TN)
Lanoxin PG
Lanoxin-PG
Lenoxicaps
Lenoxin
Lilly brand OF digoxin
Longdigox
Mapluxin
MLS000069819
MLS001055371
MLS001076495
MolPort-002-536-760
Nativelle, digoxine
Nativelle, hemigoxine
NCGC00090797-01
NCGC00090797-02
NCGC00090797-03
NCGC00090797-04
nchembio.476-comp8
Neodioxanin
neo-Lanicor
Neo-Lanicor
Novartis brand OF digoxin
Prestwick_170
Prestwick0_000437
Prestwick1_000437
Prestwick2_000437
Prestwick3_000437
Proctor and gamble brand OF digoxin
R.A.N. brand OF digoxin
Roche brand OF digoxin
Rougoxin
SK-Digoxin
SMR000059217
SMR000653537
SPBio_002393
SR-01000721866-3
ST069334
Stillacor
STOCK1N-70146
Teofarma brand OF digoxin
UDL brand OF digoxin
Vanoxin
virco Brand OF digoxin
|
|
Interventional clinical trials:
(show top 50)
(show all 66)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Mode Evaluation in Sick Sinus Syndrome Trial (MODEST) |
Unknown status |
NCT00161551
|
Phase 4 |
|
2 |
Arrhythmia Restart Prevention and RatE STabilization in Atrial Fibrillation |
Unknown status |
NCT00224341
|
Phase 4 |
|
3 |
Efficacy of a Pacemaker Algorithm in Promotion of the Intrinsic Heart Activity. |
Unknown status |
NCT00156741
|
Phase 4 |
|
4 |
Antiarrhythmic Drugs Assessment in Preventing Atrial Fibrillation |
Unknown status |
NCT02145546
|
Phase 4 |
Amiodarone;Propafenone;Sotalol |
5 |
Syncope: Pacing or Recording in the Later Years |
Unknown status |
NCT01423994
|
Phase 4 |
|
6 |
The Impact of Heart Rate on Central Blood Pressure in Sick Sinus Syndrome Patients With a Permanent Cardiac Pacemaker |
Completed |
NCT03245996
|
Phase 4 |
Atenolol Pill;Nebivolol Pill;Ivabradine Pill |
7 |
Pacing of the Atria in Sick Sinus Syndrome Trial Preventive Strategies for Atrial Fibrillation |
Completed |
NCT00161538
|
Phase 4 |
|
8 |
Austria Study - Analysis of Difference Between Active and Passive Fixation Leads |
Completed |
NCT00180557
|
Phase 4 |
|
9 |
Prevention of Atrial Arrhythmia in Patients Without Atrioventricular (AV) Conduction Disease |
Completed |
NCT01170611
|
Phase 4 |
|
10 |
Falls and Cardiovascular Events in Pacemaker Patients |
Completed |
NCT01037426
|
Phase 4 |
|
11 |
Spontaneous Atrio Ventricular Conduction Preservation |
Completed |
NCT00655213
|
Phase 4 |
|
12 |
Beta-blockers to Patients With Chronic Obstructive Pulmonary Disease |
Recruiting |
NCT03566667
|
Phase 4 |
Metoprolol;Standard care |
13 |
Virtual Clinic Pacemaker Follow-up |
Terminated |
NCT00475124
|
Phase 4 |
|
14 |
Increasing Atrial Base Rate Pacing to Reduce Atrial Fibrillation |
Completed |
NCT02317068
|
Phase 3 |
|
15 |
Mode Selection Trial in Sinus Node Dysfunction (MOST) |
Completed |
NCT00000561
|
Phase 3 |
|
16 |
Perioperative Antibiotic Therapy to Prevent Cardiac Implantable Electronic Device Infections. |
Recruiting |
NCT02809131
|
Phase 3 |
polymixin/bacitracin;cephalexin, or levofloxacin, or clindamycin;Saline |
17 |
The Danish Multicenter Randomised Study on AAI Versus DDD Pacing in Sick Sinus Syndrome |
Terminated |
NCT00236158
|
Phase 2, Phase 3 |
|
18 |
Second Study on Cardio-neuromodulation in Humans |
Unknown status |
NCT02954666
|
Phase 2 |
|
19 |
RV Septal Versus Minimized RV Pacing in Sick Sinus Syndrome |
Unknown status |
NCT01477138
|
|
|
20 |
The Role of Angiotensinogen Gene Polymorphism in the Pathogenesis of Non-familial Sick Sinus Syndrome |
Unknown status |
NCT01310920
|
|
|
21 |
The Effect of Losartan on Atrial Fibrillation (AF) Burden and Pacemaker Dependence in Patients With Sick Sinus Syndrome |
Unknown status |
NCT00647257
|
Not Applicable |
Losartan;Placebo |
22 |
Left Ventricular Function and Remodelling During Permanent Pacing |
Unknown status |
NCT00228241
|
Not Applicable |
|
23 |
Identification of Gene Polymorphism in Patients With Sick Sinus Syndrome in Chinese Population in Taiwan |
Unknown status |
NCT00314223
|
|
|
24 |
Right Ventricular Lead Placement in a Pacemaker Population: Evaluation of Apical and Alternative Position |
Unknown status |
NCT01647490
|
Not Applicable |
|
25 |
Impact of Septal Vs Apical Pacing on Right and Left Ventricular Performance |
Unknown status |
NCT01798043
|
Not Applicable |
|
26 |
Minimizing Ventricular Pacing |
Unknown status |
NCT01611389
|
Not Applicable |
|
27 |
Ventricular Pace Suppression Versus Intrinsic Rhythm Support Study |
Completed |
NCT01528657
|
Not Applicable |
|
28 |
Imaging Cardiac Electrical Remodeling With Electrocardiogram Imaging (ECGI) |
Completed |
NCT00785564
|
|
|
29 |
Right Ventricle (RV) Markers of Future Pacing Induced Ventricular Dysfunction - Pilot |
Completed |
NCT02198781
|
|
|
30 |
Beluga - Clinical Observations of Automatic Algorithms for Cardiac Pacing |
Completed |
NCT00286858
|
|
|
31 |
The Atrial High Rate Episodes in Pacemaker Patients |
Completed |
NCT00627328
|
|
|
32 |
Prospective Registry of Pacemaker Patients Concerning Percentage of Right Ventricular Pacing, LVEF and NYHA Class |
Completed |
NCT00292539
|
|
|
33 |
Left Ventricular Septum Pacing in Patients by Transvenous Approach Through the Inter-ventricular Septum |
Completed |
NCT01609738
|
|
|
34 |
SAVEPACe - Search AV Extension and Managed Ventricular Pacing for Promoting Atrio-Ventricular Conduction |
Completed |
NCT00284830
|
Not Applicable |
|
35 |
Medtronic Genetic Arrhythmia Markers for Early Detection (GAME Study) |
Completed |
NCT00664807
|
|
|
36 |
DISCOVERY: Diagnostic Data and Genetic Polymorphisms in ICD Patients. |
Completed |
NCT00478933
|
Not Applicable |
|
37 |
Brady MX a Quality Improvement Study |
Completed |
NCT02976181
|
|
|
38 |
To Pace or Not to Pace in Sinus Node Disease |
Completed |
NCT02485093
|
Not Applicable |
|
39 |
A Comparison of Rate Response Performance in Pacemaker Patients With an Indication of Sinus Node Dysfunction |
Completed |
NCT02027909
|
|
|
40 |
Evaluation of Pacemaker Algorithms to Avoid Unnecessary Right Ventricular Pacing |
Completed |
NCT01803217
|
Not Applicable |
|
41 |
Right Ventricular Outflow Tract Study |
Completed |
NCT01294839
|
Not Applicable |
|
42 |
Diagnostic Yield of an Ambulatory Patch Monitor in Unexplained Emergency Department Syncope: A Pilot Study (PATCH-ED) |
Completed |
NCT02683174
|
Not Applicable |
|
43 |
Evolution of the PR Interval in Patients Implanted With a Pacemaker Using the SafeR Mode |
Completed |
NCT02586480
|
|
|
44 |
Ingenio Device Algorithm Study |
Completed |
NCT01441583
|
Not Applicable |
|
45 |
IES-ACap: Influence of Atrial Pulse Width in the Behaviour of ACapâ„¢ Confirm Algorithm. |
Completed |
NCT00832260
|
|
|
46 |
PANORAMA Observational Study |
Completed |
NCT00382525
|
|
|
47 |
Real Life Automatic Atrial Capture Device Control |
Completed |
NCT02400983
|
|
|
48 |
Reducing Atrial Pacing Rate to Reduce Atrial Fibrillation in Patients With Sick Sinus Syndrome. |
Recruiting |
NCT02034526
|
Not Applicable |
|
49 |
Left Ventricular Pacing to Prevent Iatrogenic TR Pilot Study |
Recruiting |
NCT02314897
|
Not Applicable |
|
50 |
Left Ventricular Pacing to Avoid Cardiac Enlargement Study |
Recruiting |
NCT01302717
|
Not Applicable |
|
|